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Abstract 
Objective: To analyse economic burden of selected analgesic drugs prescription by dentists in 
Slovakia over a 24-month period. Material and Methods: In this economic burden study, the 
data were provided from the largest public health insurance company in Slovakia. It was analysed 
23,256 prescriptions of selected analgesic drugs (Acetylsalicylic Acid, Diclofenac, Nimesulide, 
Tramadol and Metamizole Sodium) by dentists in Slovakia. Results: The highest analgesics 
prescription by dentists was found in Diclofenac in 2016 with 11.2% prescription increase in 
2017. The significant decrease of analgesic drug prescription by dentists in 2017 was observed in 
Tramadol (-29.9%). The economic burden of selected analgesic drugs by patients were €33,926 in 
2017 with 21.3% significant decrease of average percentage differences (APD) in Tramadol and 
84.6% significant increase of APD in Metamizole sodium in 2017. Patients participated 65.5% 
share in payment of selected analgesic drugs and Health Insurance Company participated only 
34.5% share in payment of selected analgesic drugs in 2017. It was found increase of percentage 
analgesic drugs prescription in Diclofenac and Nimesulide and decrease of percentage drug 
prescription in Metamizole sodium from 1/2016 to 12/2017. Conclusion: Economic burden on 
analgesic drugs prescribed by dentist was low per Slovak inhabitant in calculated. Diclofenac was 
most frequent prescribed analgesic drug with the highest economic burden. We recommend 
prescribing cheaper analgesic drugs with a lower economic burden and with the same effect. 
 
Keywords: Costs and Cost Analysis; Cost of Illness; Drug Prescriptions.
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Introduction 
Orally effective opioids, acetaminophen, acetylsalicylic acid (aspirin) and non-steroidal anti-
inflamatory drugs (NSAIDs) remain the main stay of analgesic therapy of acute orofacial pain [1]. 
The current opioid abuse crisis highlights an urgent need for better paradigms for dental education 
and treatment of acute and chronic pain and addiction [2]. 
In the world, 69,000 people die in consequence of opioid overdose annual and 15 million 
population is opioid dependence [3]. 31.0% of dentists prescribe of opioids for patients 10-19y. [4]. 
Estimating the prevalence, incidence of opioid misuse is challenging, because of variable definitions 
[5]. NSAIDs and opioid analgesics are often misused as drugs [6-8]. Opioids are the most effective 
psychoactive substance for the pain treatment and suffering [9]. The adverse effects of opioids are 
drowsiness, vomiting, nausea, constipation and fatal overdoses [10]. Most opioids prescribed by 
dentists are associated with surgery [11]. Globally, Tramadol is most consumed opioid in Slovakia 
[12]. 
Dental pain is evaluated varied instruments: Dental Pain Questionnaire [13], Oral Health 
Impact Profile [14] and others. Dental pain is associated with worse socioeconomic status [15] and 
it is one of the most frequent dental discomforts [16]. 
The total economic burden of prescription opioids abuse, fatal overdose and dependence are 
estimated to be $78.5 billion in USA in 2013 [17]. There is a limited number of economic burden 
studies analysing of analgesic drugs prescription by dentists. 
The aim of this study was economic burden analyse of selected analgesic drugs prescription 
by dentists in Slovakia over a 24-month period. 
 
Material and Methods 
Study Design 
In this economic burden study, the data were provided from the largest public health 
insurance company in Slovakia.  
It was analysed 23,256 prescription of selected analgesic drugs by dentists in Slovakia. 
Selected drugs were: Acetylsalicylic Acid, Diclofenac, Nimesulide, Metamizole Sodium (NSAIDs) and 
weak opioid Tramadol. 
 
Statistical Analysis 
The statistical analyse of proportion, average percentage differences (APD) and economic 
burden of selected analgesic drugs prescription by dentists was evaluated by IBM SPSS Statistics for 
Windows Software, version 24 (IBM Corp., Armonk, NY, USA). 
The average percentage differences (APD) was calculate based on share number on equation: 
APD = n1 * 100 / n2 – 100, where, n1 is number analgesic drugs prescription in 2017 and n2 is 
number analgesic drugs prescription in 2016. 
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Results 
The selected analgesic drugs prescription by dentists in Slovakia and APD, 2016-2017 can be 
seen in the Table 1. The highest analgesic drug prescription by dentists was found in Diclofenac in 
2016 with 11.2% prescription increase in 2017. The significant decrease of analgesic drug 
prescription by dentists in 2017 was observed in Tramadol (-29.9%). 
 
Table 1. The selected analgesic drugs prescription by dentists in Slovakia and average percentage 
differences, 2016-2017 (n=23,256). 
Selected Analgesic 
Drugs 
2016 2017 APD1 (%) 
N % N %  
Acetylsalicylic Acid 115 1.0 94 0.8 -18.3 
Diclofenac 5,289 46.0 5,882 50.8 11.2 
Nimesulide 2,361 20.5 2,557 22.1 8.3 
Tramadol 418 3.6 293 2.5 -29.9* 
Metamizole Sodium 3,317 28.8 2,930 25.3 -11.7 
1Average percentage differences; *p<0.05. 
 
The economic burden of selected analgesic drugs prescription by dentists in Slovakia 
according to payment by patients, payment by health insurance company and APD, 2016-2017 can 
be seen in the Table 2.  
 
Table 2. The economic burden of selected analgesic drugs prescription by dentists in Slovakia 
according to payment by patients, payment by health insurance company and average percentage 
differences, 2016-2017 (n=23,256). 
Selected Analgesic 
Drugs 
2016 
(€) 
2017 
(€) 
APD1 
(%) 
2016 
(€) 
2017 
(€) 
APD1 
(%) 
Payment by Patients Payment by Health Insurance Company 
Acetylsalicylic Acid 207 196 -5.1 331 221 -33.3* 
Diclofenac  18,824 20,801 10.5 5,552 6,274 13.0 
Nimesulide 7,749 8,876 14.5 2,955 3,301 11.7 
Tramadol 442 348 -21.3* 4,188 2,757 -34.2* 
Metamizole Sodium 2,007 3,705 84.6* 8,343 5,309 -36.4* 
1Average percentage differences; *p<0.05. 
 
The economic burden of selected analgesic drugs by patients were €33,926 in 2017 with 
21.3% significant decrease of APD in Tramadol and 84.6% significant increase of APD in 
Metamizole sodium in 2017.  The economic burden of selected analgesic drugs by health insurance 
company were €17,862 in 2017 with significant decrease of APD in Acetylsalicylic acid (-33.3%), 
Tramadol (-34.2%) and Metamizole sodium (-36.4%) in 2017. Patients participated 65.5% share in 
payment of selected opioids and health insurance company participated only 34.5% share in payment 
of selected analgesic drugs in 2017.   
It was found increase of percentage analgesic drugs prescription in Diclofenac and 
Nimesulide and decrease of percentage opioids prescription in Metamizole sodium from 1/2016 to 
12/2017 (Figure 1). 
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Figure 1. The percentage of selected analgesic drugs prescription by dentists in Slovakia from 1/2016 
to 12/2017 (n=23,256). 
 
Discussion 
Acetylsalicylic acid (aspirin) is one from the analysed analgesic drugs which is aavailabe as 
over-the-counter (OTC) drug (without prescribing by a doctor) in Slovakia. All specialized doctors 
prescribed 1,561,486 packages (0.29 package per capita) of acetylsalicylic acid and without 
prescribing by a doctor it was bought 1,234,267 packs (0.23 package per capita) in Slovakia in 2017 
[18]. In our study, acetylsalicylic acid was prescribed only 94 packages by dentists. It can be partly 
explained that acetylsalicylic acid is often self-medicate with OTC drugs in Slovakia and lower use 
compared with that the newer NSAIDs in clinical practice in patients suffering from dental pain. 
Diclofenac was prescribed 524,644 packages by all specialized doctors (0.10 package per 
capita) in Slovakia in 2017 [18]. The highest analgesics prescription with the highest price of one 
pack (payment by patients: €3.54 per package) was found in Diclofenac by dentists. It can be partly 
explained that diclofenac is a wide proven and commonly prescribed analgesic drug with anti-
inflammatory and antipyretic properties and extensive research shows that the diclofenac 
pharmacological activity includes action novel mechanisms [19]. 
In a previous study it was found association between increased risk of liver toxicity and 
Nimesulide [20] nevertheless in our study it was observed high Nemesulide prescription (22.1%) 
with high price of one pack (payment by patients: €3.47 per pack) by dentists in 2017. 
In economic burden study [21] which analysed selected opioids prescribed by dentists in 
Brazil, it was found that expenditure share of Tramadol prescribed by dentist was 12.4%. These 
results are not corresponding with our study where expenditure share of Tramadol prescribed by 
dentist was 6.0% in 2017. It can be explained different demographic and cultural factors in pain 
therapy what it was confirmed in a previous study [22]. 
It was observed the highest the average percentage differences of payment by patients in 
Metamizole sodium, in spite of the decrease average percentage differences of payment by health 
insurance company in Metamizole sodium in 2017. 
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Conclusion 
Economic burden on selected analgesic drugs prescribed by dentists was low per Slovak 
inhabitant in calculated. Diclofenac was most frequent prescribed analgesic drug with the highest 
economic burden. We recommend prescribing cheaper analgesics with a lower economic burden and 
with the same therapeutic effect. 
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